Publication | Closed Access
High‐throughput, non‐invasive prenatal testing for fetal Rhesus D genotype to guide antenatal prophylaxis with anti‐D immunoglobulin: a cost‐effectiveness analysis
15
Citations
11
References
2018
Year
HT-NIPT is cost saving compared with providing anti-D to all RhD-negative pregnant women.
| Year | Citations | |
|---|---|---|
Page 1
Page 1